Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Norhammar

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
European Heart Journal|May 3, 2003
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarctionAnna Norhammar, Klas Malmberg, Lars Rydén, et al.
Diabetes & Vascular Disease Research|September 5, 2018
Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular functionIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational studyAnna Norhammar, Johan Bodegård, Thomas Nyström, et al.
International Journal of Cardiology|February 23, 2021
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational studyIrene Santos-Pardo, Bo Lagerqvist, Viveca Ritsinger, et al.
Journal of the American College of Cardiology|September 24, 2016
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart FailureIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Diabetes Care|June 15, 2007
IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetesMärit Wallander, Anna Norhammar, Klas Malmberg, et al.
Diabetes & Vascular Disease Research|May 22, 2014
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI studyCamilla Hage, Kerstin Brismar, Pia Lundman, et al.
Journal of Periodontology|March 12, 2021
Periodontitis, assessed using periodontal treatment as a surrogate marker, has no association with a first myocardial infarction in a Swedish populationEva Nordendahl, Michael Fored, Barbro Kjellström, et al.
European Journal of Heart Failure|January 28, 2014
Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure RegistryIsabelle Johansson, Magnus Edner, Ulf Dahlström, et al.
Journal of Endodontics|May 19, 2024
Endodontic Inflammatory Disease and Future Cardiovascular Events and Mortality: A Report from the PAROKRANK StudyDan Sebring, Kåre Buhlin, Henrik Lund, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
European Heart Journal|May 3, 2003
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarctionAnna Norhammar, Klas Malmberg, Lars Rydén, et al.
Diabetes & Vascular Disease Research|September 5, 2018
Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular functionIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Diabetes, Obesity & Metabolism|January 5, 2019
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational studyAnna Norhammar, Johan Bodegård, Thomas Nyström, et al.
International Journal of Cardiology|February 23, 2021
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational studyIrene Santos-Pardo, Bo Lagerqvist, Viveca Ritsinger, et al.
Journal of the American College of Cardiology|September 24, 2016
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart FailureIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Diabetes Care|June 15, 2007
IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetesMärit Wallander, Anna Norhammar, Klas Malmberg, et al.
Diabetes & Vascular Disease Research|May 22, 2014
The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: A report from the BEGAMI studyCamilla Hage, Kerstin Brismar, Pia Lundman, et al.
Journal of Periodontology|March 12, 2021
Periodontitis, assessed using periodontal treatment as a surrogate marker, has no association with a first myocardial infarction in a Swedish populationEva Nordendahl, Michael Fored, Barbro Kjellström, et al.
European Journal of Heart Failure|January 28, 2014
Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure RegistryIsabelle Johansson, Magnus Edner, Ulf Dahlström, et al.
Journal of Endodontics|May 19, 2024
Endodontic Inflammatory Disease and Future Cardiovascular Events and Mortality: A Report from the PAROKRANK StudyDan Sebring, Kåre Buhlin, Henrik Lund, et al.
Pageof 11